Layne Norton
Layne Norton holds a Ph.D. in Nutritional Sciences and is a professional bodybuilder and powerlifter. His published research focuses on sports nutrition, protein metabolism, and resistance training, specifically examining the effects of dietary protein and leucine on muscle protein synthesis, metabolic adaptation to weight loss, and nutritional supplementation for athletic performance.
107 claims checked on air: 13 context 5 contradicted 12 overstated 67 supported 10 unverified
What they said on air - contradicted
For people over age 65 who fall, break a bone, and are hospitalized, there is a greater than 50% chance of death within one year.
"just look at the research on people over age 65. If they fall and break something and go into the hospital, there's—I don't know the exact statistic, but I think it's better than 50% chance that they're dead within a year." (said at 0:30:50)
Large systematic reviews and meta-analyses show that one-year mortality following fracture hospitalization in older adults is substantially lower than the claimed >50%. Even for hip fractures—the most lethal major fragility fracture in this population—one-year mortality typically ranges between 10% and 25% (roughly 1 in 5 patients), well below a 50% threshold. For non-hip fractures, one-year mortality rates are even lower.
Calculations based on objective food production, availability, and waste show that Americans consume on average over 3,500 calories per day per capita.
"The more accurate way to look at it is you look at the food production, you look at food waste, and you look at food availability, and you can calculate approximately how many calories per capita people are consuming, okay? That is objective data... That data is over 3,500 calories a day on average per person" (said at 1:52:10)
The speaker conflates gross food availability (the total calories produced and supplied into the food system before waste) with loss-adjusted calorie consumption. According to the United States Department of Agriculture (USDA) Economic Research Service, gross food availability in the U.S. is roughly 3,800 to 4,000 kcal per capita per day. However, when calculations account for food loss, inedible components, and consumer food waste (which eliminates roughly 30% to 40% of available food), the USDA Loss-Adjusted Food Availability data series estimates actual daily consumption at approximately 2,400 to 2,550 calories per capita per day, well below the claimed >3,500 calories.
- context: Healthfulness of the U.S. food supply: little improvement despite decades of dietary guida… (American journal of preventive medicine 2010) · cited 112x in the literature
"Sources of data were the USDA's food availability data, loss-adjusted food availability data, and nutrient availability data, and the U.S. Salt Institute's data on salt sold for human consumption." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Daily cost of consumer food wasted, inedible, and consumed in the United States, 2001-2016… (Nutrition journal 2020) · cited 65x in the literature
"Total daily per capita food expenditure was $13.27, representing 27% wasted, 14% inedible, and 59% consumed." (abstract, results, passage verified)
pubmedfull study (doi)
In the Minnesota Coronary Experiment, the polyunsaturated fat group received substantial dietary trans fats and hydrogenated oils.
"Here's the weaknesses of the study: one, this is back when hydrogenated oils and trans fats were very prevalent in the food uh supply, and they those were considered polyunsaturated fats and they were getting a lot of their polyunsaturated fats from that. This wasn't from canola oil, this wasn't from, you know, some of these other oils. This was from hydrogenated—literally probably some of the worst source of fat you can get." (said at 1:56:40)
The speaker mischaracterizes the dietary intervention in the Minnesota Coronary Experiment (MCE) and misidentifies trans fats as polyunsaturated fatty acids. In the MCE, the intervention group's saturated fat was replaced with linoleic acid primarily derived from liquid corn oil and a specially prepared corn oil polyunsaturated margarine, significantly lowering serum cholesterol. In contrast, standard commercial margarines and shortenings (which contained significant industrial trans-fatty acids and hydrogenated oils) were part of the control diet, not the source of polyunsaturated fat in the intervention diet. Furthermore, trans-fatty acids from partial hydrogenation are predominantly trans-monounsaturated fats (such as elaidic acid), not polyunsaturated fats.
In the French NutriNet-Santé cohort, low-to-moderate aspartame consumers showed a roughly 15% increased relative risk of cancer, whereas high consumers showed no statistically significant increase in risk.
"Are you familiar with the NutriNet-Santé cohort? It's a 100,000-person study out of France... So what the headline left out was, from non-consumers of it to low-moderate consumers, it increased cancer by, I think, a relative risk of like 15%, which was significant. And then the high consumers were not significantly increased risk of cancer. The high consumers were like a relative risk increase of like a non-statistical like 4, 5%." (said at 2:34:50)
The speaker inverted the findings of the NutriNet-Santé cohort study (PMID 35324894). In that 102,865-person prospective cohort, it was the 'higher consumers' (those with intake above the median exposure among consumers) of aspartame who exhibited a statistically significant 15% increased hazard of overall cancer compared to non-consumers (HR = 1.15, 95% CI: 1.03–1.28, p = 0.002), not the low-to-moderate consumers.
- contradicts: Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based co… (PLoS medicine 2022) · cited 326x in the literature
"Compared to non-consumers, higher consumers of total artificial sweeteners (i.e., above the median exposure in consumers) had higher risk of overall cancer (n = 3,358 cases, hazard ratio [HR] = 1.13 [95% CI 1.03 to 1.25], P-trend = 0.002). In particular, aspartame (HR = 1.15 [95% CI 1.03 to 1.28], P = 0.002) and acesulfame-K (HR = 1.13 [95% CI 1.01 to 1.26], P = 0.007) were associated with increased cancer risk." (abstract, results, passage verified)
pubmedfull study (doi)
Aspirin activates both procoagulant and anticoagulant biological pathways, but its net overall physiological effect is anticoagulation.
"Like we said, aspirin activates procoagulant, anticoagulant pathways, but the overall effect is anticoagulation." (said at 48:31:45)
The claim mischaracterizes both the primary mechanism of aspirin and its physiological impact on coagulation. Aspirin acts primarily as an antiplatelet agent by irreversibly inhibiting platelet cyclooxygenase-1 (COX-1) and reducing thromboxane A2 production, thereby suppressing platelet aggregation. It does not activate procoagulant and anticoagulant plasma pathways to produce net anticoagulation. Furthermore, evaluation of coagulation parameters in healthy human subjects demonstrated that low-dose aspirin administration does not produce significant changes in endogenous thrombin potential or other metrics of thrombin generation.
Fact-checked episodes
Publications